Group 1 - The article reviews TransMedics Group, Inc. (NASDAQ: TMDX) and previously rated it as a "Strong Buy" due to its disruptive role in the healthcare industry [1] - The company is recognized for its growth potential and innovation within the healthcare sector [1]